Преждевременная недостаточность яичников: современные и перспективные подходы к улучшению функции яичников и преодолению бесплодия

1. Panay N., Anderson R.A., Bennie A., Cedars M., Davies M., Ee C. et al.; ESHRE, ASRM, CREWHIRL, and IMS Guideline Group on POI. Evidence-based guideline: premature ovarian insufficiency. Hum. Reprod. Open. 2024; 2024(4): hoae065. https://dx.doi.org/10.1093/hropen/hoae065
2. Li M., Zhu Y., Wei J., Chen L., Chen S., Lai D. The global prevalence of premature ovarian insufficiency: systematic review and meta-analysis. Climacteric. 2023; 26(2): 95-102. https://doi.org/10.1080/13697137.2022.2153033
3. Federici S., Rossetti R., Moleri S., Munari E.V., Frixou M., Bonomi M. et al. Primary ovarian insufficiency: update on clinical and genetic findings. Front. Endocrinol. (Lausanne). 2024; 15: 1464803. https://dx.doi.org/10.3389/fendo.2024.1464803
4. Салимова М.Д., Наделяева Я.Г. Преждевременная недостаточность яичников в популяционной выборке женщин Прибайкальского региона: распространённость и возрастные особенности. Acta biomedica scientifica. 2020; 5(6): 37-41.
5. Блинов Д.В., Хазан П.Л., Мнацаканьян А.Н., Корабельников Д.И., Сафаров А.Т., Павлова Н.В., Захарова Н.С., Пономарев Д.А., Петренко Д.А. Ранняя менопауза и преждевременная недостаточность яичников: проблемы и перспективы. Акушерство, гинекология и репродукция. 2020; 14(3): 328-45.
6. Аверкова В.Г., Юренева С.В. Оценка качества жизни пациенток с преждевременной недостаточностью яичников, принимающих заместительную гормональную терапию. Акушерство и гинекология. 2023; 5: 50-8.
7. Blümel J.E., Mezones-Holguín E., Chedraui P., Soto-Becerra P., Arteaga E., Vallejo M.S. Is premature ovarian insufficiency associated with mortality? A three-decade follow-up cohort. Maturitas. 2022; 163: 82-7. https://dx.doi.org/10.1016/j.maturitas.2022.06.002
8. Armeni E. Diagnostic challenges in suspected premature ovarian insufficiency. Case Rep. Womens Health. 2022; 36: e00453. https://dx.doi.org/10.1016/j.crwh.2022.e00453
9. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Аменорея и олигоменорея. 2024. 35 с.
10. Гулакова Д.М., Бойматова З.К., Юсуфбекова У.Ю., Махмаджанова М.О., Турсунова Д.Т. Критерии ультразвуковой диагностики преждевременной недостаточности яичников у женщин позднего репродуктивного возраста. Мать и дитя. 2023; 4: 19-24.
11. Дубровина С.О., Александрина А.А. Преждевременная недостаточность яичников: арсенал подходов. Акушерство и гинекология. 2022; 3: 13-20.
12. Чернуха Г.Е., Табеева Г.И., Рштуни С.Д., Машаева Р.И., Черных В.Б., Марченко Л.А. Гены, вовлеченные в развитие преждевременной недостаточности яичников. Акушерство и гинекология. 2021; 11: 71-80
13. Рштуни С.Д., Зарецкая Н.В., Кузнецова М.В. Марченко Л.А. Особенности наследования тринуклеотидных CGG повторов в гене FMR1 от женщин с преждевременной недостаточностью яичников: серия случаев. Акушерство и гинекология. 2023; 3: 91-8.
14. Тарасова А.И., Первушова М.С., Кириленко Я.В., Денисенко М.В., Соснова Е.А. Современные взгляды на проблему преждевременной недостаточности яичников. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2025; 12(2): 162-71.
15. Машаева Р.И., Марченко Л.А., Гус А.И., Костюков К.В. Овариальный возраст – ранний маркер преждевременной недостаточности яичников. Акушерство и гинекология. 2025; 3: 120-7.
16. Jiao X., Meng T., Zhai Y., Zhao L., Luo W., Liu P. et al. Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies. Front. Endocrinol. (Lausanne). 2021; 12: 601752. https://dx.doi.org/10.3389/fendo.2021.601752
17. Nelson S.M., Davis S.R., Kalantaridou S., Lumsden M.A., Panay N., Anderson R.A. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review. Hum. Reprod. Update. 2023; 29(3): 327-46. https://doi.org/10.1093/humupd/dmac045
18. Wang W.Q., Chu G.H., Hou X.X. A comparison of Doppler measures of ovarian blood flow between women with and without ovarian dysfunction and correlations of Doppler indices with ovarian dysfunction markers: a meta-analysis. Ann. Transl. Med. 2023; 11(2): 110. https://dx.doi.org/10.21037/atm-22-5813
19. Ткаченко Л.В., Гриценко И.А., Тихаева К.Ю., Свиридова Н.И., Гаврилова И.С., Долгова В.А. Оценка факторов риска и прогнозирование преждевременной недостаточности яичников. Акушерство, гинекология и репродукция. 2022; 16(1): 73-80.
20. Barros F., Carvalho F., Barros A., Dória S. Premature ovarian insufficiency: clinical orientations for genetic testing and genetic counseling. Porto Biomed. J. 2020; 5(3): e62. https://dx.doi.org/10.1097/j.pbj.0000000000000062
21. Moolhuijsen L.M.E., Visser J.A. Anti-müllerian hormone and ovarian reserve: update on assessing ovarian function. J. Clin. Endocrinol. Metab. 2020; 105(11): 3361-73. https://dx.doi.org/10.1210/clinem/dgaa513
22. Younis J.S., Iskander R., Fauser B.C.J.M., Izhaki I. Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis. Hum. Reprod. Update. 2020; 26(6): 904-28. https://dx.doi.org/10.1093/humupd/dmaa013
23. Tanbo T.G., Fedorcsak P.Z. Can time to menopause be predicted? Acta Obstet. Gynecol. Scand. 2021; 100(11): 1961-8. https://dx.doi.org/10.1111/aogs.14253
24. Liu Y., Pan Z., Wu Y., Song J., Chen J. Comparison of anti-müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis. J. Ovarian. Res. 2023; 16(1): 117. https://dx.doi.org/10.1186/s13048-023-01202-5
25. Tanaka Y., Hsueh A.J., Kawamura K. Surgical approaches of drug-free in vitro activation and laparoscopic ovarian incision to treat patients with ovarian infertility. Fertil. Steril. 2020; 114(6): 1355-7. https://dx.doi.org/10.1016/j.fertnstert.2020.07.029
26. Tang M., Sun X., Li P., Deng W., Zhan X., Sun P. et al. IL-33 and soluble ST2 in follicular fluid are associated with premature ovarian insufficiency. Front. Endocrinol. (Lausanne). 2024; 15: 1463371. https://dx.doi.org/10.3389/fendo.2024.1463371
27. Lin S., Chen S., Zhang Q. Factors influencing premature ovarian insufficiency: a systematic review and meta-analysis. J. Obstet. Gynaecol. 2025; 45(1):2469331. https://dx.doi.org/10.1080/01443615.2025.2469331
28. Du J., Wang X., Wei M., Huang Q., Bi Y., Huang W. et al. The probability and possible influence factors of intermittent ovarian function recovery in patients with premature ovarian insufficiency. Reprod. Biomed. Online. 2022; 45(6): 1275-83. https://dx.doi.org/10.1016/j.rbmo.2022.07.001
29. Cui J., Wang Y. Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment. J. Ovarian. Res. 2024; 17(1): 8. https://dx.doi.org/10.1186/s13048-023-01330-y
30. Ates S., Aydın S., Ozcan P., Bakar R.Z., Cetin C. Sleep, depression, anxiety and fatigue in women with premature ovarian insufficiency. J. Psychosom. Obstet. Gynaecol. 2022; 43(4): 482-7. https://dx.doi.org/10.1080/0167482X.2022.2069008
31. Li J., Huang Y., Xu S., Wang Y. Sleep disturbances and female infertility: a systematic review. BMC Womens Health. 2024; 24(1): 643. https://dx.doi.org/10.1186/s12905-024-03508-y
32. Muffone A.R.M.C., de Oliveira Lübke P.D.P., Rabito E.I. Mediterranean diet and infertility: a systematic review with meta-analysis of cohort studies. Nutr. Rev. 2023; 81(7): 775-89. https://dx.doi.org/10.1093/nutrit/nuac087
33. Kadir M., Hood R.B., Mínguez-Alarcón L., Maldonado-Cárceles A.B., Ford J.B., Souter I. et al. Folate intake and ovarian reserve among women attending a fertility center. Fertil. Steril. 2022; 117(1): 171-80. https://dx.doi.org/10.1016/j.fertnstert.2021.09.037
34. Громова О.А., Андреева Е.Н., Торшин И.Ю., Тапильская Н.И., Уварова Е.В. Системно-биологический анализ ролей марганца в акушерстве и гинекологии: репродуктивное здоровье женщины, регуляция менструального цикла и профилактика пороков развития плода. Вопросы гинекологии, акушерства и перинатологии. 2020; 19(1): 103-13.
35. Karimi E., Arab A., Rafiee M., Amani R. A systematic review and meta-analysis of the association between vitamin D and ovarian reserve. Sci Rep. 2021; 11(1): 16005. https://dx.doi.org/10.1038/s41598-021-95481-x
36. Bacanakgil B.H., İlhan G., Ohanoğlu K. Effects of vitamin D supplementation on ovarian reserve markers in infertile women with diminished ovarian reserve. Medicine (Baltimore). 2022; 101(6): e28796. https://dx.doi.org/10.1097/MD.0000000000028796
37. Shi Y.Q., Zhu X.T., Zhang S.N., Ma Y.F., Han Y.H., Jiang Y. et al. Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants. Front. Endocrinol. (Lausanne). 2023; 14: 1172481. https://dx.doi.org/10.3389/fendo.2023.1172481
38. Shang Y., Song N., He R., Wu M. Antioxidants and fertility in women with ovarian aging: a systematic review and meta-analysis. Adv. Nutr. 2024; 15(8): 100273. https://doi.org/10.1016/j.advnut.2024.100273
39. Xiong Y., Si Y., Quan R., Huo X., Chen J., Xu J. et al. hUMSCs restore ovarian function in POI mice by regulating GSK3β-mediated mitochondrial dynamic imbalances in theca cells. Sci. Rep. 2024; 14(1): 19008. https://dx.doi.org/10.1038/s41598-024-69381-9
40. Ma L., Li X., Li C., Chen P., Lan Y., Huang Y. et al. Association of coenzyme Q10 with premature ovarian insufficiency. Reprod. Sci. 2023; 30(5): 1548-54. https://dx.doi.org/10.1007/s43032-022-01136-1
41. Florou P., Anagnostis P., Theocharis P., Chourdakis M., Goulis D.G. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials. J. Assist. Reprod. Genet. 2020; 37(10): 2377-87. https://dx.doi.org/10.1007/s10815-020-01906-3
42. Sah P., Rai A.K., Syiem D. Sirtuin activators as an anti-aging intervention for longevity. Explor. Drug Sci. 2025; 3: 100881. https://dx.doi.org/10.37349/eds.2025.100881
43. Fiorentino G., Cimadomo D., Innocenti F., Soscia D., Vaiarelli A., Ubaldi F. et al. Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility. Hum. Reprod. Update. 2023; 29(1): 1-23. https://dx.doi.org/10.1093/humupd/dmac031
44. Bertoldo A., Pizzol D., Yon D.K., Callegari M., Gobbo V., Cuccurese P. et al. Resveratrol and female fertility: a systematic review. Int. J. Mol. Sci. 2024; 25(23): 12792. https://dx.doi.org/10.3390/ijms252312792
45. He J., Ye T., Xu K., Liu Y., Ren L. Melatonin: a potential target for regulating ovarian function. Arch. Gynecol. Obstet. 2025; 312(3): 721-31 https://dx.doi.org/10.1007/s00404-025-08079-3
46. Qi M.K., Sun T.C., Yang L.Y., He J.L., Guo Y.M., Wang H.B. et al. Therapeutic effect of melatonin in premature ovarian insufficiency: Hippo pathway is involved. Oxid. Med. Cell. Longev. 2022; 2022: 3425877. https://dx.doi.org/10.1155/2022/3425877
47. Pagano E.S., Peña J., Spinedi E. Efficacy of co-adjuvant melatonin and resveratrol chronotherapy for pregnancy achievement in premature ovarian failure (POF). Ann. Clin. Case. Rep. 2023; 8: 2454.
48. Chaudhri E.N., Salman A., Awartani K., Khan Z., Hashmi S.K. Ovarian tissue cryopreservation versus other fertility techniques for chemoradiation-induced premature ovarian insufficiency in women: a systematic review and future directions. Life. 2024; 14(3): 393. https://dx.doi.org/10.3390/life14030393
49. Chambon F., Brugnon F., Grèze V., Grémeau A.S., Pereira B., Déchelotte P. et al. Cryopreservation of ovarian tissue in pediatric patients undergoing sterilizing chemotherapy. Hum. Fertil. 2016; 19(1): 23-31. https://dx.doi.org/10.1016/j.jpedsurg.2018.12.021
50. Dolmans M.M., von Wolff M., Poirot C., Diaz-Garcia C., Cacciottola L., Boissel N. et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil. Steril. 2021; 115(5): 1102-15. https://dx.doi.org/10.1016/j.fertnstert.2021.03.008
51. Jinno M. Ovarian stimulation by promoting basal follicular growth. Reprod. Biol. Endocrinol. 2025; 23(1): 35. https://dx.doi.org/10.1186/s12958-025-01356-5
52. Vo K.C.T., Kawamura K. In vitro activation early follicles: from the basic science to the clinical perspectives. Int. J. Mol. Sci. 2021; 22(7): 3785. https://dx.doi.org/10.3390/ijms22073785
53. Khattak H., Malhas R., Craciunas L., Afifi Y., Amorim C.A., Fishel S. et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis. Hum. Reprod. Update. 2022; 28(3): 400-16. https://dx.doi.org/10.1093/humupd/dmac003
54. Liu C., Yin H., Jiang H., Du X., Wang C., Liu Y. et al. Extracellular vesicles derived from mesenchymal stem cells recover fertility of premature ovarian insufficiency mice and the effects on their offspring. Cell. Transplant. 2020; 29: 963689720923575. https://dx.doi.org/10.1177/0963689720923575
55. He J., Ao C., Li M., Deng T., Zheng S., Zhang K. et al. Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K/AKT pathway. Stem Cell Res. Ther. 2024; 15(1): 300. https://dx.doi.org/10.1186/s13287-024-03926-7
56. Yang X., Lin T., Luo L., Chen H., Dai Y., Li D. et al. Causal associations between premature ovarian insufficiency and cardiovascular diseases: a mendelian randomization study. Gynecol. Endocrinol. 2025; 41(1): 2487498. https://dx.doi.org/10.1080/09513590.2025.2487498
57. Hu L., Tan R., He Y., Wang H., Pu D., Wu J. Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies. Arch. Gynecol. Obstet. 2024; 309(2): 457-67. https://dx.doi.org/10.1007/s00404-023-07062-0
58. Hassan N., Hussein D.M., Malak F.A., Abdelaziz M.A., Boushra M.I., Shaalan W. et al. Mesenchymal stem cells: a therapeutic approach in fertility restoration in premature ovarian insufficiency. Stem Cell Rev. Rep. 2025; 21(7): 2089-2102. https://dx.doi.org/10.1007/s12015-025-10944-2
59. Moustakli E., Potiris A., Zikopoulos A., Zachariou A., Topis S., Panagopoulos P. et al. Platelet-rich plasma (PRP) in reproductive medicine: a critical review of PRP therapy in low-reserve and premature ovarian insufficiency. Biomedicines. 2025; 13(5): 1257. https://dx.doi.org/10.3390/biomedicines13051257
60. Vahabi Dastjerdi M., Sheibani S., Taheri M., Hezarcheshmeh F.K., Jahangirian J., Jazayeri M. et al. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis. Arch. Gynecol. Obstet. 2024; 309(6): 2323-38. https://dx.doi.org/10.1007/s00404-024-07442-0
61. Diaz A.A., Kubo H., Handa N., Hanna M., Laronda M.M. A systematic review of ovarian tissue transplantation outcomes by ovarian tissue processing size for cryopreservation. Front. Endocrinol. (Lausanne). 2022; 13: 918899. https://dx.doi.org/10.3389/fendo.2022.918899
62. Buckenmeyer M.J., Sukhwani M., Iftikhar A., Nolfi A.L., Xian Z., Dadi S. et al. A bioengineered in situ ovary (ISO) supports follicle engraftment and live-births post-chemotherapy. J. Tissue Eng. 2023; 14: 20417314231197282. https://dx.doi.org/10.1177/20417314231197282

Поступила 23.09.2025

Принята в печать 02.10.2025